Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Hunsicker

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Journal of Clinical Apheresis|January 1, 1994
Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapyM Wieland, V L Thiede, R G Strauss, et al.
The New England Journal of Medicine|September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesE J Lewis, L G Hunsicker, W R Clarke, et al.
Annals of Internal Medicine|November 15, 1995
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease StudyJ C Peterson, S Adler, J M Burkart, et al.
The New England Journal of Medicine|September 22, 1994
The impact of HLA mismatches on the survival of first cadaveric kidney transplantsP J Held, B D Kahan, L G Hunsicker, et al.
JAMA|October 20, 1998
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) reportH M Lin, H M Kauffman, M A McBride, et al.
Transplantation|November 7, 1999
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research GroupJ W Alexander, J A Light, L A Donaldson, et al.
Kidney International|February 13, 1999
The Banff 97 working classification of renal allograft pathologyL C Racusen, K Solez, R B Colvin, et al.
Cellr4-- Repair, Replacement, Regeneration, & Reprogramming|January 8, 2019
Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide, J Ansite, A N Balamurugan, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal of Clinical Apheresis|January 1, 1994
Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapyM Wieland, V L Thiede, R G Strauss, et al.
The New England Journal of Medicine|September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesE J Lewis, L G Hunsicker, W R Clarke, et al.
Annals of Internal Medicine|November 15, 1995
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease StudyJ C Peterson, S Adler, J M Burkart, et al.
The New England Journal of Medicine|September 22, 1994
The impact of HLA mismatches on the survival of first cadaveric kidney transplantsP J Held, B D Kahan, L G Hunsicker, et al.
JAMA|October 20, 1998
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) reportH M Lin, H M Kauffman, M A McBride, et al.
Transplantation|November 7, 1999
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research GroupJ W Alexander, J A Light, L A Donaldson, et al.
Kidney International|February 13, 1999
The Banff 97 working classification of renal allograft pathologyL C Racusen, K Solez, R B Colvin, et al.
Cellr4-- Repair, Replacement, Regeneration, & Reprogramming|January 8, 2019
Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide, J Ansite, A N Balamurugan, et al.
Pageof 8